Long-Term Safety Study of Canagliflozin (TA-7284) in Combination With Insulin in Patients With Type 2 Diabetes Mellitus
Clinical trial NCT02622113 · COMPLETED
Trial details
- NCT number
- NCT02622113
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2016-04-01
- Enrollment
- 139
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.